Testing an AI tool for diagnosing pancreatic masses
Part of Cancer, Digestive system, Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a computer program (called Joint-AI) that helps doctors look at images and biopsy samples to tell whether a pancreatic mass is cancer or not. If you are planning to have a biopsy, the AI may help make the diagnosis more accurate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have a solid mass in your pancreas seen on a CT, MRI, or ultrasound scan.
- Your doctor must think you need a biopsy (a test that takes a small tissue sample) to find out what the mass is.
- You must be willing to sign a written consent form to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence (AI) to help doctors make better decisions for people with suspected pancreatic conditions. If you are already getting a special CT scan, the AI will analyze the images to see if it can improve diagnosis and treatment planning.
This study is using an artificial intelligence tool called 'PANDA' to look at your existing CT scans to help find or evaluate pancreas conditions. It might help detect problems earlier, so your doctor can act sooner.
This study is testing how well artificial intelligence can help doctors see and understand images from an endoscopic ultrasound. If you are scheduled for this procedure, you may be able to join.
This trial uses an artificial-intelligence tool to help detect pancreatic cancer earlier and track people at higher risk. You may be asked to complete questionnaires and have imaging tests like MRI or CT to see how well the approach works.
This trial uses artificial intelligence to analyze routine CT scans of the chest or abdomen (done for other reasons) to detect early signs of pancreatic cancer. If you are already getting a CT scan for another health issue, this could help catch pancreatic cancer early without extra tests.
This study uses artificial intelligence to analyze low-dose CT scans of the abdomen to detect early signs of pancreatic cancer. It may help find cancer before symptoms appear.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.